Journals / Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi / 2021 / Cilt: 24 - Sayı: 2

MEDICAL NUTRITION THERAPY IN SHORT BOWEL SYNDROME AND FOOD INTERVENTIONS IN INTESTINAL ADAPTATION

KISA BAĞIRSAK SENDROMUNDA TIBBİ BESLENME TEDAVİSİ VE BAĞIRSAK ADAPTASYONUNDA BESİN MÜDAHALELERİ

Pages
291–297
Publication Date
2021-06-25
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

The aim of this review is to examine medical nutrition therapy in short bowel syndrome and nutritional interventions in bowel adaptation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:The 'normal' length of the small intestine ranges from 320 to 800 cm. short bowel syndrome is defined as the small bowel length less than 200 cm.
📊
Key Findings & Data:Short bowel syndrome is a clinical manifestation that occurs mainly after anatomical and / or functional loss of small intestine and presents with diarrhea, steatorrhea, weight loss, malnutrition, malabsorption, dehydration.
💡
Conclusion & Impact:The aim of this review is to examine medical nutrition therapy in short bowel syndrome and nutritional interventions in bowel adaptation.
🔬Design:Review & Systematic Survey
📍Scope:Comprehensive Sample
⚙️Variables:Intestinal adaptation · glutamine · short bowel syndrome

Abstract

The 'normal' length of the small intestine ranges from 320 to 800 cm. short bowel syndrome is defined as the small bowel length less than 200 cm. Short bowel syndrome is a clinical manifestation that occurs mainly after anatomical and / or functional loss of small intestine and presents with diarrhea, steatorrhea, weight loss, malnutrition, malabsorption, dehydration. Therefore, appropriate nutritional therapy should be planned, and lost fluid and electrolytes should be replaced. A nutritional plan should be drawn up considering other factors affecting the disease and the type of surgical procedure. The main goal of treatment in short bowel syndrome is to achieve bowel adaptation. Nutritional interventions such as glutamine, growth hormone, fish oil and probiotics-prebiotics have recently been investigated for intestinal adaptation. The aim of this review is to examine medical nutrition therapy in short bowel syndrome and nutritional interventions in bowel adaptation.

Özet

İnce bağırsağın 'normal' uzunluğu 320-800 cm arasında değişmektedir. İnce bağırsak uzunluğunun 200 cm'den daha az olması kısa bağırsak sendromu olarak tanımlanmaktadır. Kısa bağırsak sendromu, esas olarak ince bağırsağın anatomik ve/veya fonksiyonel kaybından sonra ortaya çıkan ve ishal, steatore, ağırlık kaybı, malnütriyon, malabsorbsiyon, dehidrasyon gibi bulgularla kendini gösteren klinik bir tablodur. Bu tablonun hafiflemesi için uygun beslenme tedavisi planlanmalı, kaybedilen sıvı ve elektrolitler yerine konulmalıdır. Hastalığın altında yatan faktörler ve cerrahi işlem türü dikkate alınarak beslenme planı oluşturulmalıdır. Kısa bağırsak sendromunda tedavinin en temel hedefi bağırsak adaptasyonunun sağlanmasıdır. Bağırsak adaptasyonu için son zamanlarda glutamin, büyüme hormonu, balık yağı ve probiyotikler-prebiyotikler gibi besin müdahaleleri araştırılmaktadır. Bu derlemenin amacı kısa bağırsak sendromunda tıbbi beslenme tedavisini ve bağırsak adaptasyonunda besin müdahalelerini incelemektir.

🔖

Cite This Article

KOPTAGEL, E., ALTUN, H. K. (2021). MEDICAL NUTRITION THERAPY IN SHORT BOWEL SYNDROME AND FOOD INTERVENTIONS IN INTESTINAL ADAPTATION. Anadolu Hemşirelik ve Sağlık Bilimleri Dergisi, Cilt: 24 - Sayı: 2, 291–297. https://ajindex.com/articles/216211

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (16)

  1. Pironi L, Arends J, Baxter J, Bozzetti F, Peláez RB, Cuerda C, et al. ESPEN endorsed recommendations. Definition and classification of intestinal failure in adults. Clinical Nutrition 2015;34(2):171-80
  2. Pironi L, Arends J, Bozzetti F, Cuerda C, Gillanders L, Jeppesen PB, et al. ESPEN guidelines on chronic intestinal failure in adults. Clinical Nutrition 2016;35(2):247-307
  3. Byrne TA, Nompleggi DJ, Wilmore DW. Advances in the management of patients with intestinal failure. Transplantation Proceedings 1996;28(5):2683-90
  4. Sundaram A, Koutkia P, Apovian CM. Nutritional management of short bowel syndrome in adults. J Clin Gastroenterol 2002;34 (3):207-20
  5. Nightingale J, Woodward JM. Guidelines for management of patients with a short bowel. Gut 2006;55(4):1-12
  6. Thompson JS. Inflammatory disease and outcome of short bowel syndrome. The American Journal of Surgery 2000;180(6):551-4
  7. Buchman AL, Scolapio J, Fryer J. AGA technical review on short bowel syndrome and intestinal transplantation. Gastroenterology 2003;124(4):1111-34
  8. DiBaise JK, Young RJ, Vanderhoof JA. Intestinal rehabilitation and the short bowel syndrome: Part 1. Am J Gastroenterol 2004;99(7):1386-95
  9. Jeejeebhoy KN. Short bowel syndrome: a nutritional and medical approach. Canadian Medical Association Journal 2002;166(10):1297- 302
  10. Matarese LE, Steiger E. Dietary and medical management of short bowel syndrome in adult patients. Journal of Clinical Gastroenterology 2006;40(2):85-93
  11. O'Connor TP, Lam MM, Diamond J. Magnitude of functional adaptation after intestinal resection. American Journal of Physiology 1999;276(5):1265-75
  12. Baysal A. Glutamin: Bağışıklık ve Travmalı Hastalarda Yararları. Beslenme ve Diyet Dergisi 2001:30(1):1-3
  13. Scolapio JS, McGreevy K, Tennyson GS, Burnett OL. Effect of glutamine in short-bowel syndrome. Clinical Nutrition 2001;20(4):319-23
  14. Tekin A, Yemiş M, Küçükkartallar T, Vatansever C, Çakır M, Yılmaz H, et al. The effects of oral liquid and intravenous glutamine on bowel adaptation in a rabbit short bowel syndrome model. Turkish Journal of Gastroenterology 2010;21(3): 236-43
  15. Byrne TA, Wilmore DW, Iyer K, Dibaise J, Clancy K, Robinson MK, et al. Growth hormone, glutamine, and an optimal diet reduces parenteral nutrition in patients with short bowel syndrome: a prospective, randomized, placebo-controlled, double-blind clinical trial. Annals of Surgery 2005;242(5):655-61
  16. Guo M, Li Y, Li J. Effect of growth hormone, glutam